Aerbio Company Profile

Background

Aerbio, established in 2024 through the acquisition of Deep Branch Biotechnology, is a pioneering biotechnology firm dedicated to revolutionizing sustainable protein production. By leveraging its proprietary (R)evolve™ platform, Aerbio transforms carbon dioxide and hydrogen into high-value products, notably Proton™, a protein-rich ingredient designed to meet the growing demands of the food and animal nutrition industries. The company's mission is to create a sustainable food system by producing proteins that require no arable land or fossil fuels, thereby significantly reducing the carbon footprint associated with traditional protein sources.

Key Strategic Focus

Aerbio's strategic focus centers on the development and commercialization of Proton™ through its innovative (R)evolve™ platform. This technology utilizes microbiology to convert carbon dioxide and hydrogen into sustainable products, offering a scalable and eco-friendly alternative to conventional protein production methods. The company targets multiple markets, including aquaculture, human nutrition, and pet food, aiming to provide sustainable protein solutions that address both environmental concerns and food security challenges.

Financials and Funding

In August 2024, Aerbio announced plans to raise up to €50 million in a Series A funding round, with the target close set for Q4 2024. The capital is intended to fund the construction of a demonstration-scale facility and expand the (R)evolve™ platform, setting the stage for full-scale commercial operations. The company has previously secured funding through various grants and venture capital investments, reflecting strong investor confidence in its innovative approach to sustainable protein production.

Pipeline Development

Aerbio's primary product, Proton™, is a protein-rich ingredient produced through the (R)evolve™ platform. The company has successfully launched a pilot facility at the Brightlands Chemelot Campus in the Netherlands, currently producing over 200 kg of Proton™ per month. This facility supports larger feed trials and application development. Plans are underway for a demonstration-scale facility with an anticipated production capacity of 25 tons of Proton™ annually, with the goal of having the demonstration plant online by 2026 and a commercial-scale facility operational by 2028.

Technological Platform and Innovation

Aerbio's (R)evolve™ platform is a groundbreaking technology that utilizes microbiology to convert carbon dioxide and hydrogen into valuable products. Unlike traditional fermentation processes that rely on sugar-based inputs, (R)evolve™ employs a sugar-free fermentation method, offering a sustainable and scalable alternative. This platform enables the production of Proton™, a protein-rich ingredient with a complete amino acid profile and 70% protein content. The process requires no arable land and can be deployed wherever industrial processes create food-grade carbon dioxide and hydrogen, making it highly adaptable and environmentally friendly.

Leadership Team

Kaspar Kristiansen, CEO: Guides the company's growth and strategic direction.

Rob Mansfield, CTO: Oversees technology development and innovation.

Bo Karmark, CFO: Manages financial operations and planning.

The board of directors includes Chairperson Lars Topholm, and non-executive directors Birgitte Skadhauge and Alexander Lacik, who bring extensive experience in their respective fields to support Aerbio's mission.

Leadership Changes

In 2024, Aerbio underwent a management buyout of Deep Branch Biotechnology, leading to the formation of the new company. The leadership team, including CEO Kaspar Kristiansen, CTO Rob Mansfield, and CXO Peter Rowe, continued to guide the company through this transition, ensuring continuity and stability in its strategic direction.

Competitor Profile

Market Insights and Dynamics

The sustainable protein market is experiencing significant growth, driven by increasing consumer demand for environmentally friendly and nutritious food options. Advancements in biotechnology and fermentation processes are enabling the production of alternative proteins that reduce reliance on traditional animal and plant-based sources, addressing both sustainability and food security concerns.

Competitor Analysis

Aerbio operates in a competitive landscape alongside companies such as LanzaTech, NovoNutrients, and Unibio.

LanzaTech: Specializes in converting carbon-rich waste gases into valuable chemicals and fuels using proprietary gas fermentation technology.

NovoNutrients: Focuses on transforming industrial carbon dioxide emissions into protein ingredients for aquaculture and animal feed through microbial fermentation.

Unibio: Utilizes a unique gas fermentation process to produce single-cell protein for animal feed, emphasizing sustainability and scalability.

These competitors are also leveraging gas fermentation technologies to produce sustainable proteins, highlighting the growing interest and investment in this innovative approach to protein production.

Strategic Collaborations and Partnerships

Aerbio collaborates with industry leaders to advance its mission. Notable partnerships include working with the Sustainable Aquaculture Innovation Centre (SAIC), AB Agri, and BioMar as part of the REACT-FIRST initiative, which involves collaboration across the entire value chain to develop sustainable protein solutions.

Operational Insights

Aerbio's strategic considerations focus on leveraging its (R)evolve™ platform to produce Proton™ efficiently and sustainably. By utilizing carbon dioxide and hydrogen as feedstocks, the company reduces reliance on traditional agricultural inputs, offering a scalable solution that can be deployed in various locations. This approach provides a distinct competitive advantage by addressing both environmental sustainability and food security challenges.

Strategic Opportunities and Future Directions

Aerbio's strategic roadmap includes scaling up production capabilities through the construction of demonstration and commercial-scale facilities. The company aims to expand its market presence by targeting applications in aquaculture, human nutrition, and pet food. By continuously innovating and optimizing its (R)evolve™ platform, Aerbio is well-positioned to meet the growing demand for sustainable protein solutions and contribute to a more sustainable global food system.